(Q34663266)

English

A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Daniel M. Moreira

object named as

Daniel M Moreira

2

0 references

Martha K Terris

object named as

Martha K Terris

6

0 references

author name string

Howard S Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Matthew R Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Joseph C Presti

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

William J Aronson

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Christopher J Kane

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Christopher L Amling

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Stephen J Freedland

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

22 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

924-928

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Prostate specific antigen only progression of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055926

7 July 2018

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Long-term effects of androgen deprivation therapy in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09679.X

21 January 2018

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20860651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20860651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20860651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/20860651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1464-410X.2010.09679.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34663266&oldid=1633973791"